- Home
- PRKS vs VKTX Comparison
PRKS vs VKTX Comparison
Compare PRKS & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- VKTX
- Stock Information
- Founded
- PRKS 1959
- VKTX 2012
- Country
- PRKS United States
- VKTX United States
- Employees
- PRKS N/A
- VKTX N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- PRKS Health Care
- VKTX Health Care
- Exchange
- PRKS Nasdaq
- VKTX Nasdaq
- Market Cap
- PRKS 2.8B
- VKTX 3.0B
- IPO Year
- PRKS 2013
- VKTX 2015
- Fundamental
- Price
- PRKS $53.50
- VKTX $33.61
- Analyst Decision
- PRKS Buy
- VKTX Strong Buy
- Analyst Count
- PRKS 11
- VKTX 12
- Target Price
- PRKS $57.73
- VKTX $86.42
- AVG Volume (30 Days)
- PRKS 820.9K
- VKTX 5.3M
- Earning Date
- PRKS 11-06-2025
- VKTX 10-22-2025
- Dividend Yield
- PRKS N/A
- VKTX N/A
- EPS Growth
- PRKS N/A
- VKTX N/A
- EPS
- PRKS 3.77
- VKTX N/A
- Revenue
- PRKS $1,707,446,000.00
- VKTX N/A
- Revenue This Year
- PRKS $0.85
- VKTX N/A
- Revenue Next Year
- PRKS $2.30
- VKTX N/A
- P/E Ratio
- PRKS $14.17
- VKTX N/A
- Revenue Growth
- PRKS N/A
- VKTX N/A
- 52 Week Low
- PRKS $37.68
- VKTX $18.92
- 52 Week High
- PRKS $60.83
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- PRKS 55.85
- VKTX 62.67
- Support Level
- PRKS $53.52
- VKTX $25.04
- Resistance Level
- PRKS $55.71
- VKTX $32.85
- Average True Range (ATR)
- PRKS 1.49
- VKTX 1.49
- MACD
- PRKS 0.15
- VKTX 1.01
- Stochastic Oscillator
- PRKS 61.51
- VKTX 88.54
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.